117 related articles for article (PubMed ID: 12009665)
1. Extracellular matrix composition and cellular mechanisms of transplant vasculopathy in rat aortic allografts.
Religa P; Bojakowski K; Bojakowska M; Gaciong Z; Thyberg J; Hedin U
Transplant Proc; 2002 Mar; 34(2):687-8. PubMed ID: 12009665
[No Abstract] [Full Text] [Related]
2. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
Lácha J; Lehmann M; Chadimová M; Brock J; Havlícková J
Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129
[No Abstract] [Full Text] [Related]
3. Transplantation-induced endothelial dysfunction as studied in rat aorta allografts.
Andriambeloson E; Pally C; Hengerer B; Cannet C; Nikolova Z; Bruns C; Zerwes HG; Bigaud M
Transplantation; 2001 Dec; 72(12):1881-9. PubMed ID: 11773884
[TBL] [Abstract][Full Text] [Related]
4. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
[No Abstract] [Full Text] [Related]
5. Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins.
Religa P; Bojakowski K; Gaciong Z; Thyberg J; Hedin U
Mol Cell Biochem; 2003 Jul; 249(1-2):75-83. PubMed ID: 12956401
[TBL] [Abstract][Full Text] [Related]
6. Arteriosclerosis in rat aortic allografts: early changes in endothelial integrity and smooth muscle phenotype.
Bojakowski K; Religa P; Bojakowska M; Hedin U; Gaciong Z; Thyberg J
Transplantation; 2000 Jul; 70(1):65-72. PubMed ID: 10919577
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction and denudation in rat aortic allografts.
Andriambeloson E; Bigaud M; Schraa EO; Kobel T; Lobstein V; Pally C; Zerwes HG
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):67-73. PubMed ID: 11145935
[TBL] [Abstract][Full Text] [Related]
8. Transplantation-induced functional/morphological changes in rat aorta allografts differ from those in arteries of rat kidney allografts.
Andriambeloson E; Cannet C; Pally C; Klanke B; Bruns C; Zerwes HG; Bigaud M
Am J Transplant; 2004 Feb; 4(2):188-95. PubMed ID: 14974939
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
Stoltenberg R; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplant Proc; 1994 Oct; 26(5):2569-70. PubMed ID: 7940794
[No Abstract] [Full Text] [Related]
10. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
[TBL] [Abstract][Full Text] [Related]
11. Effects of immunosuppressive therapy on the rat aortic allograft model.
Steele DM; Hullett DA; Bechstein WO; Kowalski J; Smith LS; Kennedy E; Allison AC; Sollinger HW
Transplant Proc; 1993 Feb; 25(1 Pt 1):754-5. PubMed ID: 8438469
[No Abstract] [Full Text] [Related]
12. N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.
Wedel J; Hottenrott MC; Bulthuis M; Huitema S; Yard BA; Hillebrands JL
Transplantation; 2016 Jan; 100(1):80-90. PubMed ID: 26674731
[TBL] [Abstract][Full Text] [Related]
13. Clinical and experimental chronic allograft rejection.
Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen A; Koskinen P; Ustinov J; Lautenschalger I; Taskinen E
Transplant Proc; 1994 Jun; 26(3):1702-3. PubMed ID: 8030092
[No Abstract] [Full Text] [Related]
14. Sequential immunological targeting of chronic experimental arterial allograft.
Plissonnier D; Nochy D; Poncet P; Mandet C; Hinglais N; Bariety J; Michel JB
Transplantation; 1995 Sep; 60(5):414-24. PubMed ID: 7676487
[TBL] [Abstract][Full Text] [Related]
15. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
[TBL] [Abstract][Full Text] [Related]
16. FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model.
Fukada J; Schena S; Tack I; Ruiz P; Kurimoto Y; Pang M; Aitouche A; Abe T; Striker LJ; Pham SM
Circ Res; 2000 Jul; 87(1):66-72. PubMed ID: 10884374
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
[TBL] [Abstract][Full Text] [Related]
18. Estimation of graft arteriosclerosis after allogeneic fresh and cryopreserved aortic transplantation in the rat.
Gabriel M; Fändrich F
Transplant Proc; 2002 Mar; 34(2):711-2. PubMed ID: 12009674
[No Abstract] [Full Text] [Related]
19. Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts.
Tori M; Kitagawa-Sakakida S; Li Z; Izutani H; Horiguchi K; Ito T; Matsuda H; Shirakura R
Transplantation; 2000 Sep; 70(5):737-46. PubMed ID: 11003350
[TBL] [Abstract][Full Text] [Related]
20. Correlation between proliferating cell nuclear antigen expression and phenotypic change in smooth muscle cells during the development of vasculopathy in heterotopically transplanted rat hearts.
Shirasawa B; Hamano K; Ueda M; Kojima A; Kobayashi T; Ito H; Gohra H; Katoh T; Zempo N; Esato K
Transplant Proc; 2000 Nov; 32(7):1995-6. PubMed ID: 11120035
[No Abstract] [Full Text] [Related]
[Next] [New Search]
